Subscribe To
Kineta to present at jefferies healthcare conference
SEATTLE, May 23, 2023 (GLOBE NEWSWIRE) — Kineta, Inc. (Nasdaq: KA), a clinical-stage biotechnology company focused on the development of ...
May 23, 2023, 10:30 am
Ocugen to present at bio international convention 2023
MALVERN, Pa., May 23, 2023 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, de...
May 23, 2023, 8:00 am
Kineta to present at jefferies healthcare conference
SEATTLE, May 23, 2023 (GLOBE NEWSWIRE) -- Kineta, Inc. (Nasdaq: KA), a clinical-stage biotechnology company focused on the development of ...
May 23, 2023, 6:30 am
Aerovate therapeutics presents nonclinical pharmacokinetic data in support of av-101, a novel dry powder inhaled formulation of imatinib, at the american thoracic society (ats) 2023 international conf
Direct delivery of imatinib to the lungs in nonclinical species demonstrated increased lung exposure compared with oral or IV dosing Formulation impac...
May 22, 2023, 5:15 pm
Milestone pharmaceuticals: worthy of a dart throw
Today, we take a deeper look at Milestone Pharmaceuticals Inc. for the first time on Seeking Alpha. The company's primary drug candidate has a ...
May 22, 2023, 2:37 pm
Celularity announces phase 1 data showing that mlasc therapy in patients with crohn’s disease may be a therapeutic option to manage inflammatory bowel diseases and prevent fistula formation
Early-stage data presented at the 26th Annual Meeting of the American Society for Gene and Cell Therapy demonstrate that therapy with placental-derive...
May 19, 2023, 8:21 pm
Sab biotherapeutics presents virtual 2023 r&d day portfolio update: breakthrough immunotherapy innovations
SIOUX FALLS, S.D., May 19, 2023 (GLOBE NEWSWIRE) — SAB Biotherapeutics (NASDAQ: SABS), a clinical-stage biopharmaceutical company with a ...
May 19, 2023, 12:30 pm
Ultragenyx to present at the 2023 barclays – gene editing & gene therapy summit
NOVATO, Calif., May 19, 2023 (GLOBE NEWSWIRE) — Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the developmen...
May 19, 2023, 12:30 pm
Taysha gene therapies presents preclinical data on tsha-102 for rett syndrome demonstrating cellular regulation of mecp2 expression in key mouse models at the american society of gene and cell therapy
New preclinical data after neonatal administration in wild-type mice showed no detectable impact on survival, neurobehavioral functions and overall he...
May 19, 2023, 12:00 pm
Ultragenyx to present at the 2023 barclays - gene editing & gene therapy summit
NOVATO, Calif., May 19, 2023 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development...
May 19, 2023, 8:30 am
Clientearth challenges uk court dismissal of shell climate lawsuit
ClientEarth, an environmental law charity turned activist Shell investor, said on Friday it was challenging a London court decision to dismiss its
May 18, 2023, 8:15 pm
Why is enveric biosciences (envb) stock up 120% today?
Enveric Biosciences (NASDAQ: ENVB ) stock is enlivened amid an otherwise soft early afternoon session on Wall Street, delivering triple-digit percenta...
May 18, 2023, 3:06 pm
Mink’s novel fap-car-inkt presented at asgct
FAP-CAR-IL-15 iNKT cell therapy (MiNK-215) promotes curative responses driving tumor elimination and immune infiltration in NSCLC models IND enabling ...
May 18, 2023, 12:30 pm
Zymeworks announces departure of neil klompas, president and chief operating officer
VANCOUVER, British Columbia, May 18, 2023 (GLOBE NEWSWIRE) — Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing novel,...
May 18, 2023, 12:30 pm
Voyager therapeutics presents robust, multi-species results from preclinical studies of iv-delivered, tracer™-generated novel capsids at the asgct 26th annual meeting
Oral presentation features further evaluation of second-generation capsids, demonstrating increased transduction in several brain areas across multipl...
May 18, 2023, 10:00 am
Netflix's (nflx) new danish movie expands international content
Netflix (NFLX) is expanding its international content with the adaptation of Karen Blixen's novel, Ehrengard, starring Sidse Babett Knudsen of Borgen ...
May 17, 2023, 2:20 pm
Sientra announces fda-clearance of novel portfinder™ technology
Continued Innovation Showcases Sientra’s Leadership in Reconstruction Surgeries IRVINE, Calif., May 17, 2023 (GLOBE NEWSWIRE) — Sientra, Inc. (NAS...
May 17, 2023, 12:30 pm
As smot stumbled after a vigorous start, a fresh review is necessary
SMOT is a comparatively novel investment vehicle targeting attractively valued small- and mid-sized U.S...
May 16, 2023, 11:11 pm
Is novo nordisk stock a screaming buy right now?
Novo Nordisk's rocket-fueled growth in type 2 diabetes and obesity treatment has made its stock a winning play for two straight years. With ...
May 16, 2023, 10:45 am
Livent stock charges higher as lithium prices bounce
When it comes to investing in electric vehicle growth, Livent Corp. NYSE: LTHM is one of the most promising companies. As EVs go from novelties to mai...
May 16, 2023, 9:36 am